07-Apr-2021

Pyrazinamide Market is accounted for US$ 143.9 million in 2020 with 4.6% CAGR by 2027, Says CMI

SEATTLE, April 07, 2021, (PHARMIWEB) — Global Pyrazinamide Market analysis

The rising prevalence of tuberculosis (TB) is a vital factor which is expected to stimulate growth of the global pyrazinamide market. As per the National Center for Biotechnology Information (NCBI), around 8,920 new cases of TB were reported in U.S. in the year 2019. The source also reported that the rate of TB is about 2.7% in 100,000 people. The TB Facts Report Organization Data revealed that the cost for treatment of drug sensitive TB was around US$ 49,000 while the cost for treating MDR-TB is US$ 393,000 on average and the cost for treating XDR-TB is US$ 758,000 on average.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/4317

Impact of Coronavirus (COVID-19) Pandemic

The outbreak of COVID-19 epidemic has hindered growth of the healthcare industry. For instance, in December 2019, the health authorities of Wuhan City of China had reported a cluster of pneumonia cases which was later identified as a novel member called COVID-19. Since then, this virus had spread rapidly globally with a considerable number of infections. The World Health Organization (WHO) had declared the COVID-19 as a global epidemic in March 2020, and further recommended the implementation of strict lockdowns to reduce the transmission of the disease. This pandemic has affected the healthcare sector by slowing down the growth of the sector and creating disturbances in the supply chain of pharmaceutical drugs.

Furthermore, the governments of several countries had implemented the national lockdowns to limit the transmission of the pandemic. The healthcare organizations across various countries are facing issues regarding the continuity of their supply chain operations. This slowdown in the supply chain has affected growth of the global pyrazinamide market.

In 2020, the global pyrazinamide market has an estimated value of US$ 143.9 million. This market is expected to witness a CAGR of 4.6% over the forecast period (2020-2027).

Fig. 1. Global Pyrazinamide Market Share (%) Analysis, By Patient Type, 2020

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4317

Restraints

Rising infection of pyrazinamide drug resistant TB is the major factor which is expected to restrain growth of the global pyrazinamide market.

Market Segmentation

According to Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

According to Patient Type: Adult, Pediatric.

Fig.2. Global Pyrazinamide Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Regional Analysis

Owing to the rising incidences of TB patients across the U.S. and Canada, the North American region is expected to experience a robust growth in the global pyrazinamide market. In 2019, the Center for Disease Control and Prevention reported around 8.916 new cases of TB in U.S. In 2017, the Canadian government reported a total of 1,796 new cases of TB in Canada which is higher than 1,750 cases in 2016, signifying a 2.6% increment.

The high number of TB patients is attributing growth of the pyrazinamide market in European region. In 2017, the European Center for Disease Prevention and Control reported around 55,337 new cases of TB with the rate of disease at 10.7 per 100,000 people.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/pyrazinamide-market-3578

Major players contributing in the global pyrazinamide market are Toronto Research Chemicals, Acros Organics, AlliChem, Waterstone Technology, City Chemical, Pure Chemistry Scientific, LGM Pharma, TCI, HBCChem, and Alfa Chemistry

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Patient Type
  - Market Snapshot, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Market Trends
- Key Developments
- Impact Analysis
- Mergers & Acquisitions
- New Product Launch
- Technology Overview
- PEST Analysis
Global Pyrazinamide Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID 19 Impact Analysis
- New Developments
Global Pyrazinamide Market, By Patient Type, 2016 – 2027, (US$ million)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Adult
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Pediatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Pyrazinamide Market, By Distribution Channel, 2016 – 2027, (US$ million)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Pyrazinamide Market, By Region, 2016– 2027, (US$ Million)
- Introduction
  - Market Share Analysis, By Patient Type, 2020 and 2027 (%)
  - Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, By Region, 2017 – 2027
  - Regional Trends
- North America
  - Market Share Analysis, By Patient Type, 2020 and 2027 (%)
  - Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - U.S.
    - Canada
- Europe
  - Market Share Analysis, By Patient Type, 2020 and 2027 (%)
  - Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Share Analysis, By Patient Type, 2020 and 2027 (%)
  - Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Share Analysis, By Patient Type, 2020 and 2027 (%)
  - Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Market Share Analysis, By Patient Type, 2020 and 2027 (%)
  - Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Market Share Analysis, By Patient Type, 2020 and 2027 (%)
  - Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
  - Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
Section
- References
- Research Methodology
- About Us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

Company:
- CDN Newswire

Last Updated: 07-Apr-2021